Market Report, "Celgene Corporation: PharmaVitae Profile", published

May 20, 2011 - PRLog -- Introduction

This analysis examines the historical and forecast performance for Celgene in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Features and benefits

* Gain insight into Celgene's strategic outlook across the next 6 years* Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source

Highlights

Strategic insight into the prospects for King over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales.
Your key questions answered

* Benchmark Celgene's performance against key rivals in the prescription pharmaceutical sector* See how Celgene, having experienced tremendous growth, will continue to see positive growth over the forecast period

------------------------------------------------------------
Full Report Details at
- http://www.fastmr.com/prod/158629_celgene_corporation_pha...
------------------------------------------------------------


Report Table of Contents:

Executive Summary
Key findings
Prescription pharmaceutical sales and growth rate analysis, 2003-
Financial performance, 2003-
Celgene: PharmaVitae forecasts at a glance
Strategic insight
Increased scale through M&A
Profit expansion post M&A
Revlimid remains central to Celgene's performance to
SWOT analysis
Strengths
Weaknesses
Opportunities
Threats
ABOUT THIS PROFILE
PharmaVitae Explorer database
Chapter structure
Quarterly news update
Company introduction
Company sales
Company financials
Key products and competitors
Data sourcing
Analyst consensus
QUARTERLY NEWS UPDATE
Latest comment
Latest prescription pharma product news
Q2
Latest corporate news
Q3
Q2
Q1
COMPANY INTRODUCTION
Key findings
Background
Key corporate developments
M&A history
Historical divestment generates capital
Minor acquisitions permit steady expansion
Pharmion acquisition is central to Celgene's future growth
Gloucester Pharmaceuticals acquisition provides boost to launch portfolio
Abraxis acquisition completed in early Q4
Current corporate structure
Pharmaceuticals
Collaborative agreements
Royalty revenue
COMPANY SALES
Key findings
Prescription pharmaceutical sales and growth rate analysis, 2003-
Product analysis
Product analysis, 2003-
Product analysis, 2009-
Therapy area analysis
Geographic analysis
Launch/core/expiry analysis
Explanation of launch/core/expiry analysis
Launch analysis, 2009-
Core analysis, 2009-
Expiry analysis, 2009-
Launch/core/expiry configuration, 2009-
Molecule type analysis
Externalization analysis
COMPANY FINANCIALS
Key findings
Reconciliation between PharmaVitae-formatted prescription pharma sales and company-reported total sales, 2003-
Operating costs and profit analysis
Operating costs and profit analysis, 2003-
Operating cost ratio and profit margin analysis, 2003-
Operating cost ratio and profit margin analysis, 2009-
Operating costs and profit analysis, 2009-
KEY PRODUCTS AND COMPETITORS
Key findings
Overview
Oncology
Vidaza
Thalomid
Amrubicin
Abraxane
CC-4047 (pomalidomide)
Istodax
APPENDIX
R&D pipeline
References
Abbreviations

About Datamonitor

The Datamonitor Group is a world-leading provider of premium global business information, delivering independent data, analysis and opinion across the Automotive, Consumer Markets, Energy & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. Datamonitor's market intelligence products and services ensure that you will achieve your desired commercial goals by giving you the insight you need to best respond to your competitive environment.  View more research from Datamonitor at http://www.fastmr.com/catalog/publishers.aspx?pubid=1002

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.